+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Optical Disorders Drugs Market Research Reports

Choroideremia Treatment Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Treatment Type, Distribution Channel, Route of Administration, Region, By Country: 2020-2030 - Product Thumbnail Image

Choroideremia Treatment Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Treatment Type, Distribution Channel, Route of Administration, Region, By Country: 2020-2030

  • Report
  • May 2024
  • 325 Pages
  • Global
From
Juvenile Macular Degeneration (Stargardt Disease) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Juvenile Macular Degeneration (Stargardt Disease) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • April 2024
  • 70 Pages
  • Global
From
Neurotrophic Keratitis Market Outlook 2023-2036 - Product Thumbnail Image

Neurotrophic Keratitis Market Outlook 2023-2036

  • Report
  • January 2024
  • 155 Pages
  • Global
From
Glaucoma Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Thumbnail Image

Glaucoma Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • September 2023
  • 121 Pages
  • Global
From
Geographic Atrophy Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access - Product Thumbnail Image

Geographic Atrophy Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access

  • Report
  • July 2023
  • 29 Pages
  • Global
Optic Nerves Disorder Treatment Market by Treatment Type, Indication, Distribution Channel, and Geography: Forecast up to 2027 - Product Thumbnail Image

Optic Nerves Disorder Treatment Market by Treatment Type, Indication, Distribution Channel, and Geography: Forecast up to 2027

  • Report
  • July 2023
  • 145 Pages
  • Global
From
Retinal Vein Occlusion Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Retinal Vein Occlusion Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 92 Pages
  • Global
From
Macular Edema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Macular Edema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 79 Pages
  • Global
From
Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 286 Pages
  • Global
From
Optic Neuritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Optic Neuritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 63 Pages
  • Global
From
Keratoconjunctivitis sicca (Dry Eye) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Keratoconjunctivitis sicca (Dry Eye) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 292 Pages
  • Global
From
Bacterial Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bacterial Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 31 Pages
  • Global
From
Ocular Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ocular Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 112 Pages
  • Global
From
Proliferative Vitreoretinopathy (PVR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Proliferative Vitreoretinopathy (PVR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 37 Pages
  • Global
From
Ocular Drug Delivery: Market Overview, Delivery Technologies and Partnering Opportunities, 2nd edition - Product Thumbnail Image

Ocular Drug Delivery: Market Overview, Delivery Technologies and Partnering Opportunities, 2nd edition

  • Report
  • November 2020
  • 199 Pages
  • Global
Retinopathy Of Prematurity - Pipeline Review, H2 2020 - Product Thumbnail Image

Retinopathy Of Prematurity - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 68 Pages
  • Global
From
Eye Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Eye Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 134 Pages
  • Global
From
Africa Ophthalmic Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032 - Product Thumbnail Image

Africa Ophthalmic Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032

  • Report
  • August 2025
  • 100 Pages
  • Africa
From
China Ophthalmic Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032 - Product Thumbnail Image

China Ophthalmic Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032

  • Report
  • August 2025
  • 80 Pages
  • China
From
France Ophthalmic Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032 - Product Thumbnail Image

France Ophthalmic Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032

  • Report
  • August 2025
  • 80 Pages
  • France
From
Loading Indicator

The Optical Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat eye-related conditions. These drugs are used to treat a variety of conditions, including glaucoma, cataracts, macular degeneration, and dry eye syndrome. The market is composed of both generic and branded drugs, with the latter typically being more expensive. The market is highly competitive, with many large pharmaceutical companies vying for market share. Companies such as Allergan, Bausch + Lomb, Novartis, and Pfizer are all major players in the Optical Disorders Drugs market. Additionally, there are many smaller companies that specialize in the development and production of these drugs. Overall, the Optical Disorders Drugs market is an important part of the pharmaceutical industry, providing treatments for a variety of eye-related conditions. Show Less Read more